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13) Glc NAc–Ser(thr) - N – acetyl Glucosamine – Serine (Threonine) 
14) Asn – Glc NAc - Asparagine – N – Acetyl glucosamine 
15) ZPI – 3 - Zonapellucida Glycoprotein 1-3 
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17) Gly  CAM 1 - Glycan bearing cell adhesion molecule 1 
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19) ICAM - Intercellular adhesion Molecule 
20) LFA - Lymphocyte function associated antigen 
21) PECAM - Platelet Endothelial cell adhesion Molecule 
22) ER - Endoplasmic Reticulum 
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24) ICD – 10 - International Statistical Classification of diseases and  
   related health problems 
25) WHO - World Health Organisation 
26) DSM IV - Diagnostic and statistical manual of mental disorders 
27) OD - Optical density 
28) SD - Standard Deviation 
29) PBH - Protein Bound Hexose 
30) PBHx - Protein Bound Hexosamine 
31) NaoH - Sodium Hydroxide 
32) Hcl - Hydrochloric Acid 
33) H2SO4 - Sulphuric acid 
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INTRODUCTION 
 The presence of protein bound carbohydrate in serum has been 
recognized for many years. The early work in this field was reviewed in 
1929 by Grevenstuk in an extensive paper and also in 1933 by 
Rimington. 
 Many investigators have demonstrated that the concentration of 
the glycoprotein in human serum is abnormally high in a number of 
physiological and pathological states1. Evidence has accumulated 
showing that there are a number of distinct serum glycoproteins and that 
the concentrations of these may vary in an independent manner2. 
 Glycoproteins can be simply defined as proteins that have 
carbohydrate moiety covalently attached to their peptide portion. 
Glycoproteins as a group have multiple and complex function and are 
found as enzymes, hormones, blood group substances and as 
constituents of extra cellular membrane. These are organic compounds 
composed of both a protein and carbohydrates usually hexose, 
hexosamine, fucose, sialic acid joined together covalently linked to 
polypeptide chain. The level of different types of serum glycoproteins 
are maintained within a narrow range in health but is elevated in many 
pathological conditions like tuberculosis3, autoimmune disease, 
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cardiovascular disease, Ischemic heart disease4, Diabetes Mellitus, 
cancer cervix5, uterus and breast, psychiatric disorder2. 
 In psychiatric disorder such as schizophrenia, elevated levels of 
serum glycoprotein has been reported6. The present study is to evaluate 
the changes in the level of serum glycoproteins as protein bound hexose, 
protein bound hexosamine in patients with depressive disorder and 
compared with normal healthy subjects as control. Most of the work has 
involved determination of total glycoproteins from the content of protein 
bound hexose and protein bound hexosamine2. 
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AIM AND OBJECTIVES 
 In psychiatric diseases, Major depressive disorder is most 
common. The glycoproteins vary in their relative content of serum of 
four monsaccharides. The net change in the total level would also vary 
depending upon the monosaccharide used for determination. In 
psychiatric disorders such as schizophrenia, elevated levels of serum 
glycoprotein has been reported. 
 It was thought of interest to investigate the changes in the levels 
of serum glycoproteins in patients with  depressive disorder. 
 The aim of this study is to estimate and compare the level of 
serum glycoproteins as protein bound hexose and protein bound 
hexosamine in patients with  severe depressive disorder  and  normal 
subjects. 
To evaluate whether the levels of serum glycoproteins are 
elevated in depressive disorder and serve as a marker in diagnosis of the 
patients with severe depression. 
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REVIEW OF LITERATURE 
 A great number of studies have indicated that the concentration 
of the serum glycoproteins may be makedly increased in patients or in 
experimental animals suffering from a wide variety of pathological 
conditions. 
 Most of the work in this field has involved determination of the 
total Glycoproteins from the content of protein bound hexose or 
hexosamine. 
 Mukesh Nandave, SK Ojha et al reported the changes in levels of 
serum glycoproteins in Major depressive disorder. He had concluded 
that serum glycoprotein levels may serve as an indicator of Major 
depressive disorders7. 
 Opeolu M. Adoeye, Robert E. Ferrell et al reported that Alpha 1 
acid glycoprotein level rise as a result of increased hepatic synthesis 
stimulated by the inflammatory cytokines8. 
 Nieto E, vieta E Alvarez et al reported that plasma level of alpha 
1 Acid glycoprotein is increased in Major depressive disorder and its 
relationship to severity, response to treatment and imipramine plasma 
levels9. 
Narendra G. Mehta and Alamela Venkataraman had studied the 
level of serum glycoprotein in  various diseases10. 
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Fatemi SH, Kroll JL, Stary JK11 had studied the altered levels of 
Reelin and its isoforms in mood disorders (Bipolar disorder and major 
depression) and schizophrenia. They reported that blood Reelin levels 
and its  isoforms may be used as potential peripheral markers to 
diagnose presence of several psychiatric disorders and may also serve as 
targets for further therapeutic interventions. 
Sluzewska A, Rybakowski JK et al12 reported high level of Alpha 
-1-acid glycoproteins and its microheterogencity in patients with major 
depressive disorder. 
Bondy B. Baghai TC, Minov C et al13 reported increased levels of 
substance ‘P’  in major depression. 
Healy D, Calvin J, White house AM et al14 studied about the 
level of Alpha -1- acid glycoprotein in major depressive and eating 
disorders. 
Kehoe WA, Kwentus JA, Sheffol WB, Harralson AF15, reported 
increased alpha 1 – acid glycoprotein in depression lowers free fraction 
of imipramine. 
Bruce EC, Mussel Man DL16 studied about depression, 
alterations in platelet function and Ischemic heart disease. They 
observed that depression is also associated with complex platelet 
abnormalities.  
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GLYCOPROTEINS 
TERMINOLOGY2 
 The committee on protein Nomenclature of the American 
Physiological society and the American Society of Biochemists defined 
Glycoproteins as, “the compounds of the protein molecules with a 
substance or substances containing a carbohydrate group other than 
Nucleic acids”. 
 The amount of protein bound carbohydrate in serum is a direct 
measure of the serum glycoprotein levels, as carbohydrates other than 
glucose is a constituent of many serum proteins i.e. glycoproteins. 
 The serum glycoprotein levels were most frequently been 
determined and expressed in terms of hexose and hexosamine content. 
GLYCOPROTEIN SHOWING LINKED  
CARBOHYDRATES ON ITS SURFACE.
Reproduced from Stryer L Biochemistry  5th edn pg. 307. 
 7 
TYPES OF GLYCOPROTEINS 
 Glycoproteins may be two general types2. 
They are 
1) Mucoproteins 
2) Mucoids. 
1) Mucoproteins are proteins bonded to carbohydrate through 
polar linkage which are relatively easily split in an electric 
field, by concentrated salt or by alkaline solutions. 
Eg : - Mucopoly saccharides 
2) Mucoids are glycoproteins in which the carbohydrate is 
covalently bonded to the protein. 
Eg : - ovo mucoid, seromucoid 
 The extensively studied serum “Mucoprotein” of winzler et al is 
considered as having a mucoid nature since the carbohydrates can be 
split from the protein by drastic treatment. This is a heterogenous 
fraction that is left in solution by perchloric acid and precipitated by 
phosphotungstic acid. It is essentially identical with the serum fraction 
isolated in 1897 by Zanotti et al from filtrates of serum deproteinated by 
heat coagulation and subsequently studied Bywaters and Rimington. 
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 The fraction was designated as seromucoid by all of the early 
investigators. It is appropriate to replace the term plasma mucoprotein 
with the established term seromucoid. 
 The Major component in human seromucoid is an 
electophoretically and ultracentrifugally distinct acidic glycoprotein 
which has been crystallized and quite well characterized by chemical, 
physical and immunological Method. 
NATURE OF SERUM GLYCOPROTEINS17 
 About 200 Monosaccharides are found in Nature. However only 
eight are commonly found in oligosaccharide chains of glycoproteins. 
 The principal sugars found in human glycoproteins are as 
follows. 
S.No Sugar Type Abbreviation Nucleotide Sugar 
1. Galactose  Hexose Gal UDP-Gal 
2. Glucose  Hexose Glc UDP-Glc 
3. Mannose Hexose Man GDP – Man 
4. N-Acetyl 
neuraminic 
acid 
Sialic acid Neu Ac CMP – Neu Ac 
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5. Fucose  Deoxy 
hexose 
Fuc  GDP – Fuc 
6. N-Acetyl 
galactosamine 
Amino 
hexose 
Gal NAc UDP – Gal NAc 
7. N-Acetyl 
glucosamine 
Amino 
hexoxe  
GlC NAc UDP – Glc NAc 
8. Xylose Pentose  Xyl UDP - xyl 
Mannose is the common sugar in N-linked glycoproteins. N-
Acetyl neuraminic Acid is usually found at the terminals of 
oligosaccharide chains, attached to sub terminal galactose or N-acetyl 
galactosamine residues. 
 The other sugars listed are generally found in more internal 
positions. Sulfate is often found in glycoproteins usually attached to Gal, 
Gal NAc or Glc NAc. 
Structure of principal sugars found in Human glycoproteins 
 
Reproduced from Harper’s Illustrated Biochemistry 26th edn 
pg 104. 
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N- ACETYL NEURAMINIC ACID 
 
 
 
 
 
β – L FUCOSE ( 6 – DEOXY β – L – GALACTOSE) 
 
 
 
 
N- ACETYLGLALACTOSAMINE SULFATE 
 
 
 
 
N-ACETYLGLUCOSAMINE 
 
 
 
 
H 
OH 
OH 
H 
Reproduced from Harper’s Biochemistry, 24th edition, Page 144. 
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On the average the normal human serum contains2,  
1) Protein bound hexose 121 + 2.1 mg% as galactose – Mannose 
2) Protein bound hexosamine  83.4 + 4.1 mg%  
3) Protein bound fucose 8.9 + 0.6 mg%  
4) Protein sialic acid 60 + 3.1 mg%  
The galactose and Mannose are present in about equal amounts. 
The protein bound carbohydrates of serum distributed among 
different protein fractions. The partition of serum into fractions of 
varying carbohydrates content has been carried out by neutral salts, 
ethanol precipitation and by electrophoresis. 
 Orosomucoid,  the acidic glycoprotein isolated from human 
serum by Schmid.K. and by Weimer et al has been shown to have the 
mobility of ∝1 globulin in veronal buffer at pH 8.6. 
 Schmid.K18 has demonstrated in the supernatant from fraction V 
prepared by low temperature – low salt – ethanol method, three 
additional low molecular weight, acidic glycoproteins with mobilities  of  
∝2 globulin at pH8.6. The hexose and hexosamine contents of these 
glycoproteins were between 6 & 4%. 
 The other carbohydrate containing proteins that have been 
demonstrated in serum include prothrombin, gonadotropin, c4 
component of complement. 
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MAJOR CLASSES OF GLYCOPROTEINS19 
 Glycoproteins are divided into 3 major classes based on the 
nature of linkage between their polypeptide chains and the 
oligosaccharide chains. 
1) Those containing an O-glycosidic linkage (o-linked) involving 
the hydroxyl side chain of serine or threonine and a sugar such as 
N-acetyl galactosamine. 
2) Those containing N – glycosidic linkage (N-linked) involving the 
amide nitrogen of asparagine and N-acetyl glucosamine. 
3) Those linked to the carboxyl terminal amino acid of a protein via 
a phosphoryl- ethanolamine moiety joined to an oligosaccharide 
which in turn is linked via glucosamine to phosphatidyl inositol. 
This is referred as GPI – anchored (Glycosyl phosphatidyl 
Inositol. Anchored) Glycoproteins 
4) Glycophorin-an important red cell membrane glycoprotein 
contains both o- and N- linked oligosaccharides. 
Glycosyl Phosphatidyl Inositol Linkage 
 
 
 
 
Reproduced from Harper’s Illustrated Biochemistry, 26th edition, Page 519. 
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SUBCLASSES OF O-GLYCOSIDIC LINKAGES 
1) Gal NAc – Ser (Thr) linkage is the predominant linkage. 
Two typical oligosaccharide chains found in member of this 
subclass are sub maxillary mucins and Fetuin and in the 
sialoglycoprotein of the membrane of human red blood cells.  
2) Proteoglycans contain a Gal – Gal – xyl – Ser trisaccharide. 
(link trisaccharide) 
3) Collagens contain a Gal – hydroxy lysine linkage. 
4) Nuclear proteins and cytosolic proteins contain side chains 
consiting of a single GlcNAc attached to a serine or threonine 
residues [GluNAc – Ser (Thr)] 
 
 
 
 
 
 
 
 
Reproduced from Stryer L.  Biochemistry 5th edition, page 306. 
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CLASSES OF N-TERMINAL LINKED GLY COPROTEINS 
• The three major classes of N-linked oligosaccharides are 
complex, hybrid and high – mannose. 
• N-linked glycoprotein is the major class of glycoprotein. 
• They are distinguished by the presence of their Asn – GlcNAc 
linkage. 
• It includes both membrane bound and circulating glycoproteins. 
• Each type share a common pentasacchacide, Man3GlcNac2. 
• The presence of the common pentasaccharide is explained by the 
fact that all three classes share an initial common mechanism of 
Biosynthesis. 
• Glycoproteins of complex type generally contains terminal 
NeuAc residues and underlying Gal and GlcNAc residues, the 
latter often constituting the disaccharide N-acetyl lactosamine. 
• Repeating N-acetyl actosamine units are often found on N- linked 
glycan chains. 
• The oligosaccharide branches are often referred to as antennae, so 
that bi, tri and tera and penta – antennary structures may all the 
found. 
• High – mannose oligosaccharides typically have two to six 
additional Man residues linked to the pentasaccharide core. 
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• Hybrid molecules contain features of both of the two other 
classes 
 
 
 
 
 
 
 
Reproduced from Stryer L.  Biochemistry 5th edition, page 306. 
 
 
 
 
Complex Type 
  
N Linked Oligosaccharides – High Mannose Type 
Reproduced from Stryer L. Biochemistry 5th Edn. Page 306. 
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FUNCTIONS OF GLYCOPROTEINS: 
 The oligosaccharide chains encode considerable biological 
information and this depends on upon their constituent sugars, their 
sequences and their linkages. 
The functions of oligosaccharide chains of glycoprotein are. 
1) Modulate physico chemical properties.  
Eg:- Solubility, viscosity, charge, conformation, 
denaturation, binding sites for bacteria and virus.  
2) Protect against proteolysis, from inside and outside of the cell. 
3) Affect proteolytic processing of precursor proteins to smaller 
products. 
4) Involved in biological activity. Eg. Humanchorionic 
gonadotropin. 
5) Affect insertion into membranes, intracellular migration, 
sorting and secretion. 
6) Affect embryonic development and differentiation. 
7) May affect sites of metastases selected by cancer cells. 
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FUNCTIONS SERVED BY GLYCOPROTEINS 
S.No. Function Glycoprotein 
1) Structural Molecule Collagens 
2) Lubricant and protective agent Mucins 
3) Transport Molecule Transferrin 
ceruloplasmin 
4) Immunologic molecule Immunoglobulins, 
histocompatibility 
antigens. 
5) Hormone Choronic gonadotropin, 
thyroid stimulating 
hormone. 
6) Enzyme Various eg. Alkaline 
phosphatase 
7) Cell attachment – recognition site Various proteins 
involved in cell-cell, 
virus – cell, bacterium-
cell, and hormone – cell 
interactions. 
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8) Antifreeze Certain plasma proteins 
of cold water fish. 
9) Interact with specific carbohydrates  Lectins, selectins, 
antibodies 
10) Receptor Various proteins 
involved in hormone 
and drug action 
11) Affect folding of certain proteins Calnexin, calreticulin. 
 
ROLE OF GLYCOPROTEIN IN FERTILIZATION:-  
• Zona pellucida (ZP), a thick transparent, non cellular envelope 
surrounds the oocyte. 
• It has three glycoprotein, ZP 1-3. Of particular note is ZP3, an O-
linked glycoprotein that function as a receptor for the sperm. 
• A protein on the sperm surface, possibly galactosyl transferase, 
interacts specifically with oligosaccharide chains of ZP3. 
• This interaction by transmembrane signaling, induces the  
acrosomal reaction, in which enzymes such as proteases and 
hyaluonidase and other contents of the acrosome of the sperm are 
released. 
 19
• Liberation of these enzymes helps the sperm to pass through the 
zona pellucida and reach the plasma membrane of the oocyte. 
• These interactions enable the sperm to enter and thus fertilize the 
oocyte. 
• It may be possible to inhibit fertilization by developing drugs or 
antibodies that interfere with the normal functions of ZP3 and 
thus they act as contraceptive agents. 
ROLE OF GLYCOPROTEIN–SELECTIN IN INFLAMMATION17 
• Leukocytes play important roles in many inflammatory and 
immunologic phenomena. 
• Leukocytes and endothelial cells contain on their surfaces 
specific lectins, selectins that participate in their intercellular 
adhesion.  
• Selectins are single – chain Ca2+ binding transmembrane proteins 
that contain a number of domains. 
• Their aminoterminal ends contain the lectin domin, which is 
involved in binding to specific carbohydrate ligands. 
• The adhesion of neutrophils to endothelial cell of post capillary 
venules occur in four stages. 
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Stage I - Slowing or rolling of the neutrophils mediated by  
selectins. 
Stage II - Interactions between L-Selectin on the neutrophil  
surface and CD34 and GlyCAM -1 on the 
endothelial surface. 
Stage III - Activation of the neutrophils by various chemical  
mediators resulting in a change of shape of the 
neutrophils and firm adhesion of these cells to the 
endothelium. 
- LFA-1 (Lymphocyte function – associated antigen– 
1) and Mac -1 (Integrins) on the neutrophils and 
ICAM -1 and ICAM -2 (Inter cellular adhesion 
molecule) are involved in firm adhesion. 
Stage IV - Transmigration of the neutrophils across the  
  endothelial wall. Platelet – endothelial cell adhesion 
molecule – 1 (PECAM -1) localized at the junction 
of endothelial cells and plays a role in 
transmigration. 
The three selectin molecules P – selectin, L-selectin, E-selectin 
bind sialylated and fucosylated oligosaccharides and in particular all 
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three bind sialyl Lewis x, a structure present on both glycoprotein and 
glycolipids. 
MUCIN– GLYCOPROTEIN HAVE HIGH CONTENT OF 0- 
LINKED OLIGOSACCHARIDES:- 
Mucins are glycoproteins having two major characteristics:- 
1) High content of O-linked oligosaccharides. The carbohydrate 
content of mucin in more than 50%. 
2) Presence of repeating Amino acid sequence (tandem repeats) in 
the centre of their polypeptide backbones, to which the O-glycan 
chains are attached in clusters. These sequence are rich in serine, 
threonine and proline. 
TYPES OF MUCINS 
1) Secretory Mucin 
2) Membrane bound Mucin 
• The high content of O-glycans confers an extended structure on     
mucins.         
• The extended structure contributes to their high viscoelasticity. 
• This is due to the steric interactions between their Gal Nac moieties 
and adjacent amino acids, resulting in a chain – stiffening effect. 
• The high content of NeuAc and sulfate residue in mucins confers a 
negative charge on them. 
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BIOSYNTHESIS OF GLYCOPROTEINS 
 Liver is a major source of the serum glycoproteins. This is based 
on the observation by Werner that the serum Glycoprotein content of 
rabbit serum was increased following removal of blood from rabbits. 
This increase is no longer occurred when liver damage was produced by 
intoxication with phosphorus or Benzene. One this basis, Werner.I20 
suggested that the glycoproteins may play a role in the synthesis of 
serum proteins in the liver. 
The possibility that the liver is involved in the synthesis of some 
of the components of seromucoid is suggested by the observations of 
Greenspan et al. 
SYNTHESIS OF O-LINKED GLYCOPROTEINS:- 
• The polypeptide chains of O-linked and other glycoprotein are 
encoded by mRNA species. 
• These Glycoproteins are built up by the stepwise donation of sugars 
from nucleotide sugars such as UDP – GalNac, UDP – Gal and 
CMP-NeuAc. 
• The enzymes catalyzing this type of reaction are membrane bound 
glycoprotein glycosyl transferases.  
• The factors that determine which specific serine and threonie 
residues are glycosylated have not been identified but are probably 
found in peptide structure surrounding the glycosylation site. 
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• The enzymes assembling O-linked chains are located in the Golgi 
apparatus, sequentially arranged in an assembly line with terminal 
reactions occurring in the trans – Golgi compartments. 
SYNTHESIS OF N-LINKED GLYCOPROTEIN21  
• N-linked glycoprotein acquires their initial sugar from Dolichol 
donors. 
• The oligosaccharide destined for attachment to the asparagine 
residue of a protein is assembled attached to dolichol phosphate, a 
specialized lipid molecule contaning as many as 20 isoprene (c5) 
units. 
• Dolichol phosphate resides in the Endoplasmic Reticulum membrane  
• The terminal phosphate group is the site of attachment of the 
activated oligosaccharide and is transferred to the protein acceptor. 
STAGES OF ASSEMBLY:- 
1) 2 N-acetylglucosamine residues and 5 mannose residues are 
added to the dolichol phosphate through the action of a number of 
cytoplasmic enzymes that catalyse monosaccharide transfer from 
sugar nucleotides. 
2) This structure is then “Flipped” through the ER membrane into 
the lumen of ER. 
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3) Finally, additional enzymes are added by enzymes in the ER 
lumen. This result in the formation of a 14 residue 
oligosaccharide attached to dolichol phosphate. 
4) This is then transferred en block to a specific asparagine residue 
of the growing polypeptide chain. 
Assembly of an N-linked Oligosaccharide precursor on Dolichol 
phosphate. 
 
 
 
 
 
 
 
 
Reproduced from Stryer L. Biochemistry, 5th edn. Page 308. 
PROTEIN GLYCOSYLATION21 
• Protein glycosylation takes place inside the lumen of the 
Endoplasmic reticulum and golgi complex. 
• The N-linked glycosylation begins in the ER and continues in the 
Golgi complex. 
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• The O-linked glycosylation takes place exclusively in the golgi 
complex.  
TRANSPORT OF THE PROTEIN FROM ER TO GOLGI FOR 
FURTHER GLYCOSYLATION AND SORTING21 
• Proteins in the lumen of ER and in the ER membrane are transported 
to the golgi complex. 
• The carbohydrate units of glycoproteins are altered and elaborated in 
the golgi complex. 
• The proteins proceed from golgi complex to lysosomes, secretory 
granules according to the signals encoded within their Amino acid 
sequence and three – dimensional structures. 
GOLGI COMPLEX AS SORTING CENTRE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reproduced from Stryer L, Biochemistry, 5th Edn, page. 309.
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PHYSIOLOGICAL SIGNIFICANCE OF SERUM 
GLYCOPROTEINS2 
 
Sibert F.B. et al suggested the elevations of Glycoprotein above 
normal level reflect process of tissue destruction.  In support of the view 
that tissue destruction contributes directly to the serum glycoprotein 
levels is the observation that more glycoprotein carbohydrate is found in 
venous blood than in arterial blood. 
Direct release of preformed glycoprotein from inflamed tissue is 
a possibility.  Equally possible is the increased local synthesis and 
liberation of the glycoprotein by inflammation tissue. 
The increased serum glycoprotein levels in disease reflect in 
whole or in part, processes associated with tissue proliferation26,27. 
Elevations in serum glycoproteins are frequently associated with 
conditions in which destruction is not pronounced and cell proliferation 
or protein syntheis is rapid. Eg. prostatic hyperplasia, pregnancy. 
Elevated serum glycoproteins may represent a systemic response 
to non-specific stress. The wide variety of conditions which result in 
high serum glycoprotein levels would tend to support this contention 
and would suggest that the levels of serum glycoproteins might be 
affected by the pituitary adrenal axis. 
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DEPRESSIVE DISORDER: 
 Major Mood disorders comprised of Mood episodes including 
Major depressive episode, Manic episode, Mixed episode and 
hypomanic episode.  
DEFINITION22 
 The term depression can define an affect, mood state, a disorder 
or syndrome, or a specific entity. 
 A depressed ‘affect’ usually occurs in response to a specific 
situation and is best defined as a relatively transient state of feeling 
‘depressed’, ‘sad’ or ‘blue’. 
 A depressed ‘Mood’ is more pervasive, experienced as unusual or 
atypical, associated with negative ideas and may influence behaviour. 
A depressed ‘condition’ is distinguished by a longer duration, by more 
or greater number of clinical features and by distinct social impairment. 
The addition of several clinical features informs about severity i.e major 
and minor depressive disorders.  
 Depressive conditions are described as primary or secondary. 
‘Secondary depression’ emerges during the course a substantive 
psychiatric condition eg. Schizophrenia or Medical condition or 
following triggering factors like organic states, substance abuses 
including alcoholism. 
 28
HISTORY23 :- 
 Mood disorders were recognized in ancient times. In the late 
1800s and early 1900s Emil Kraeplin distinguished the syndromes of 
depression and mania from the deteriorating course of schizophrenic 
illness in adult population. 
 In psychiatric diseases, Major depressive disorder is most 
common and it may range from a very mild condition, bordering to 
normality, to severe depression accompanied by hallucinations and 
delusion. 
EPIDEMIOLOGY: - PREVALENCE  
 The life time prevalence of Major depressive disorder in 
adolescents is between 15-20% similar to that in adult population.   
• 40-70% of children and adolescents have comorbid psychiatric 
disorders and 50% have two or more comorbid disorder. 
• 10-80% of the time disruptive behaviour disorders co-occur with 
major depressive disorder. 
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MAJOR DEPRESSION PREVALENCE RATE 
(Point or 1 – year) 
Pre schoolers 0.3% 
Children 0.4-3% 
Adolescents  0.4-6.4% 
 
• Race, Poor school performance and socio economic status were 
inconsistently associated with depressive disorders among youths 
ETIOLOGY OF DEPRESSIVE DISORDER23 
1. GENETICS:- 
Genetic factors are of major importance as risk factors for 
vulnerability to major depression. 
 Traditional estimates have put the heritability at about 40%. 
• Kindler et al estimated heritability by about 70%. 
• The genes for Major depression do not appear to be unique for 
depression, but overlap with the genes for anxiety and the genes for 
neuroticism 
• Wilhelm et al, suggested that the greater prevalence of depression in 
women is due to the strong association of anxiety and neuroticism 
with depression. 
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• The higher rates of anxiety and neuroticism in women lead to higher 
rates of depression. 
2. GENDER:- 
• The ratio of women to men in Major depression is approximately 2:1 
• The increased rate of Major depression in women arises during 
puberty. 
• In childhood, there is a slightly higher prevalence of depression in 
boys than girls. 
3. COGNITIVE FACTORS:- 
• Cognitive distortions and negative attributions are commonly 
observed among depressed children, adolescents and adults. 
• The notion of learned helpless, first proposed by Martin Seligman 
describes the cognitive experience of a person who perceives 
unpredictable and uncontrollable events as the basis for feeling 
helpless and powerless. 
• Another form of cognitive distortion observed in depressed persons 
is the belief that they are responsible for negative events that may be 
uncontrollable. 
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4) ENVIRONMENTAL FACTORS:- 
• Marital status is a risk factor for Major depression. 
• Separated or divorced men have the highest rates of Major 
depression than married men. 
• Lack of paid employment is also a risk for the development of an 
episode of depression. 
• Family conflict is the more frequent precipitating event in 
adolescents with suicidal behaviour. 
5) ADVERSE LIFE EVENTS 
• 70% of children and adolescents with new-onset depression have an 
adverse life event in the 12 months preceding the depression 
compared with 29% controls. 
• Stressful life events include interpersonal losses, relationship failures 
divorce, bereavement and exposure to a suicide. 
• A study of Major depression in preschoolers found that 100% of the 
subjects had been victims of neglect or abuse. 
6) CHILDHOOD EXPERIENCES:- 
• Loss of a parent in Child hood increased the later risk for Major 
depression. 
• Lack of parental care is associated with increased rates of depression. 
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• Child hood sexual abuse is established as a risk factor for adult 
Major depression. 
7) PERSONALITY:- 
• Individuals who are unduly anxious, impulsive and obessional may 
have increased rate of later major depression. 
8) PHYSICAL ILLNESS:- 
• A chronic or severe physical illness is associated with an increased 
risk for depression. 
• In Parkinson’s disease, there are shared neurotransmitter 
abnormalities between the disease and depression. 
• In Post – stroke depression, there is good evidence that the location 
of the lesion contributes to the rate of depression. 
• This suggests a neurotansmiter connection between the physical 
illness and likelihood of depression. 
9) BIOLOGICAL FACTORS:- 
1) Hypothalamic – pituitary axis 
About half of all patients with Major depression have a raised 
cortisol output, which tends to return to normal on recovery. Cortisol is 
always regarded as a stress hormone and is severed in response to 
various types of acute stress. The idea that there is a relatively specific 
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link between chronic high cortisol level and mood disorder is notably 
persistent. 
 It has also been suggested that elevated serum glycoproteins may 
represent a systemic response to non-specific stress2. The wide variety 
of conditions which result in high serum glycoprotein levels tend to 
support this contention and would suggest that the levels of serum 
glycoprotein might be affected by the pituitary – adrenal axis. 
Abnormal cortisol secretion in adults with major depressive 
disorder was demonstrated with overall elevation of 24hr basal 
secretion, non suppression on a Dexamethasone challenge test, (DST) 
blunting of normal diurnal rhythms and increased nocturnal cortisol 
secretion. 
2. SEROTONIN:- 
 Some evidence in adult studies indicates that a dysregulation of 
the serotonin system might contribute to the development of depression. 
This hypothesis is based on the blunted response of cortisol secretion to 
serotonergic agents used to challenge the system. 
Other studies have found that brains of suicide completers 
contain an increased postsynaptic Number of serotonin receptors in the 
prefrontal cortex, suggesting that this increase in receptors may be a 
mechanism to compensate for decreased serotonin release. 
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3. GROWTH HORMONE : - 
 Growth hormone secretion i.e blunted in response to insulin – 
induced hypoglycemia during the depressive episode as well as after 
resolution of depression. 
 Blunted growth hormone response may be a trait marker for 
depression since it occurs among children who have had depression 
even after the depression has remitted. 
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CRITERIA FOR DIAGNOSING DEPRESSIVE 
DISORDER 
 
• There are number of criterias for depression which includes 
Diagnostic and statistical Manual of Mental disorders III and IV 
(DSM III & IV) and the 10th revision of International statistical 
classification of Diseases and Related Health problems (ICD – 10), 
according to WHO. (World Health organization) 
• The present study on  Depressive disorder patients is based on ICD – 
10 criteria. 
ACUTE DEPRESSION AS DEFINED IN DSM – IV AND ICD – 10 
Symptoms of Depression DSM – IV ICD - 10 
1. Depressed Mood most of the day, 
nearly every day 
+ + 
2. Markedly diminished interest or 
pleasure in all or almost all, activities 
most of the day, nearly every day 
+ + 
3. Loss of energy or fatigue nearly 
every day 
+ + 
4. Loss of confidence or self – esteem - + 
5. Unreasonable feeling of self – 
reproach or excessive or 
inappropriate guilt nearly every day 
+ + 
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6. Recurrent thoughts of death or 
suicide or suicidal behaviour 
+ + 
7. Diminished ability to think or 
concentrate or indecisiveness, nearly 
every day 
+ + 
8. Psychomotor agitation or retardation 
nearly every day  
+ + 
9. Insomnia or hypersomnia nearly 
every day 
+ + 
10. Change in appetite (decrease or 
increase) with corresponding weight 
change 
+ + 
 
CLASSIFICATION OF AFFECTIVE MOOD DISORDERS 
a) Formal classification 
b) Hierarchical or tiered model – clinical classification. 
FORMAL CLASSIFICATION:- 
 The ICD – 10 systems classify the depressive disorder into 3 
types. 
1) Mild depressive episode 
2) Moderate depressive episode 
3) Severe depressive episode. 
In the present study, the patients with  Depressive disorder are 
diagnosed based on ICD – 10 criteria. 
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GENERAL CRITERIA (F32) 
1) Depressive episode should last for at least 2 weeks  
2) No hypomanic or manic symptoms at anytime in the 
individual’s life. 
3) Episode not attributable to psychoactive substance use or to 
any organic mental disorder.  
MILD DEPRESSIVE EPISODE (F32.0) 
A) General criteria must be met. 
B) At least 2 of 3 following symptoms:- 
a) Depressed Mood to a degree which is abnormal for the individual 
present for most of the day and almost every day. Uninfluenced 
by circumstances and sustained for at least 2 weeks. 
b) Loss of interest or pleasure in activities that are normally 
pleasurable. 
c) Decreased energy or increased fatigability  
C) ANY 4 OF THE FOLLOWING SYMPTOMS:- 
a) Loss of confidence or self – esteem 
b) Unreasonable feeling of self reproach or excessive and 
inappropriate guilt. 
c) Recurrent thoughts of death or suicide or any suicidal behaviour. 
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d) Complaints or evidence of diminished ability to think or 
concentrate such as indecisiveness or vacillation. 
e) Change in psychomotor activity with agitation or retardation. 
f) Sleep disturbance of any type. 
g) Change in appetite decreased or increased with corresponding 
weight change.  
MODERATE DEPRESSIVE EPISODE (F32.1) 
A) General Criteria must be met. 
B) At least 2 or 3 symptoms from F32.0 Criteria B. 
C) Additional symptoms from F32.0 Criteria C, to give a total of at least 
Six. 
SEVERE DEPRESSIVE EPISODE (F32.2) 
A) General Criteria F32 
B) All 3 symptoms in criteria B, F32.0 
C) Additional symptoms from F32.0 Criteria C to give a total of at least 
8. 
D) No hallucinations, delusion or depressive stupor. 
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MATERIALS AND METHODS 
 The present study was carried out after getting approval from the 
Ethical Committee, Stanley Medical College, Chennai. 
 The study was carried out for a period of four months from June, 
06 to September 06. 
 The patient with Depressive disorder was selected from the 
outpatient department, Department of psychiatry, Stanley Medical 
College Hospital, Chennai and Madras Medical College Hospital, 
Chennai. 
 The blood samples were analyzed and serum glycoprotein levels 
were estimated as protein bound hexose and protein bound hexosamine 
in the Department of Biochemistry Stanley Medical College, Chennai. 
 The study was carried out on 100 subjects comprising 50 normal 
healthy volunteers and 50 patients with severe depressive disorder with 
the range of age 25-55 yrs. 
 Healthy Normal subjects were selected on the basis of good 
health as evidenced by the Medical history, complete physical 
examination and routine laboratory tests performed prior to the 
commencement of the study. Informed consent was obtained from the 
healthy normal subjects. 
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CASE SELECTION: 
 The diagnosis of patients with Severe Depressive disorder was 
performed using International classification of Disease – 10 criteria 
(ICD – 10) by a clinical psychologist. Informed and written consent was 
obtained from the legal guardian of the patients. 
 ICD – 10 criteria for the diagnosis of  Depressive disorder24. 
General criteria (F32) 
1) Depressive episode should last for at least 2 weeks. 
2) No hypomanic or Manic symptoms at any time in the individual’s 
life. 
3) Episode not attributable to psychoactive substance use or to any 
organic mental disorder. 
MILD DEPRESSIVE EPISODE (F 32.0) 
A) General Criteria(F 32) must be met. 
B) At least 2 – 3 following symptoms : - 
b) Depressed mood to a degree which is abnormal for the individual 
present for most of the day and almost every day uninfluenced by 
circumstances and sustained for at least 2 weeks. 
c) Loss of interest or pleasure in activities that are normally 
pleasurable. 
d) Decreased energy or increased fatigability.  
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C) Any 4 of the following symptoms :- 
a) Loss of confidence or self – esteem 
b) Unreasonable feeling of self reproach or excessive and 
inappropriate guilt. 
c) Recurrent thoughts of death or suicide or any suicidal behaviour. 
d) Complaints or evidence of diminished ability to think or 
concentrate such as in decisiveness or vacillation. 
e) Change in psychomotor activity with agitation or retardation. 
f) Sleep disturbance of any type 
g) Change in appetite increased or decreased with corresponding 
weight change. 
MODERATE DEPRESSIVE EPISODE : - (F32.1) 
A) General Criteria F32 must be met. 
B) At least 2 of 3 symptoms for F 32.0 criteria B must be present. 
C) Additional symptoms from F32.0 criteria C, to give a total of 
atleast  6. 
SEVERE DEPRESSIVE EPISODE :- (F32.2) 
A) General Criteria F32 must be met. 
B) All three symptoms in criteria B, F32.0 must be present. 
C) Additional symptoms from F32.0 Criteria C to give a total of at 
least 8. 
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D) No Hallucinations, delusion or depressive stupor. 
 
EXCLUSION CRITERIA  
¾ H/o.  Cardiovascular disease 
¾ H/o. Pulmonary tuberculosis 
¾ H/o. Trauma, prolonged bed rest 
¾ H/o. carcinoma cervix, breast 
¾ H/o. chronic alcoholism 
¾ H/o. diabetes, hypertension 
SAMPLE COLLECTION AND PROCESSING:- 
 Blood samples (3-5ml) were collected from the normal subjects 
and from the patients with  severe depressive disorder. After collection 
the blood samples were centrifuged to separate the serum. The 
Biochemical analysis was performed on serum samples for estimation of 
protein bound hexose and protein bound hexosamine. All the reagents 
were of analytical reagent (AR) grade. 
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ESTIMATION OF SERUM GLYCOPROTEINS2:- 
1. Protein Bound hexose :- 
 Protein bound hexose was estimated by the method of 
Weimer.H.E., and Moshin.J.R. 
 In this Method, the hexose moiety of glycoprotein conjugates 
precipitated by ethanol at room temperature. Is then determined by 
orcinol reaction and read at 540nm. 
STANDARDIZATION OF THE PROCEDURE: - 
 A galactose – Mannose standard is employed as the serum 
glycoproteins contains only these two hexoses in approximately equal 
amounts. Since the optical density varies with the different hexoses, the 
standard should contain the same sugars in the same proportions as 
occur in the unknown. 
 Hexosamine and fucose components known to be present in 
serum glycoproteins, do not interfere with the determination at 540nm 
Preparation of standard solution:- 
 Galactose – Mannose standard 0.2mg/ml = 0.1mg/ml each of 
galactose and Mannose. 
• Stock solution – 100mg each to galactose and Mannose was 
dissolved in 100ml of deionised water. 
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• Working standards of different conversation prepared from the stock 
solution. 
Working standard 
concertration 
Stock solution  
(ml) 
Deionised water  
(ml) 
10mg% 1 9 
20mg% 2 8 
30mg% 3 7 
40mg% 4 6 
50mg% 5 5 
REAGENTS 
1) 95% Ethanol 
2) Orcinol – H2S04 Reagent 7.5 volumes of Reagent A mixed fresh 
daily with 1 volume of Reagent B. 
Reagent A : 60ml con. H2S04 and 40ml of H20  
Reagent B : 1.6gml of orcinol in 100ml H20  
0.2mg/ml Galactoso – Mannose standard. 
PROCEDURE: 
1) To 0.1ml of serum in a 15x150mm test tube, 5ml of 95% ethanol 
was added and mixed. 
2) Centrifuged for 15 minutes, decanted and suspended the 
precipitate in 5ml of 95% ethanol centrifuged and decanted. 
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3) Dissolved the precipitated proteins in 1ml of 0.1N NaoH. 
4) Blank – 1ml of H20  and 1ml of standard solution was taken in a 
test tube. 
5) 8.5 ml of orcinol – sulphuric acid Reagent is added to all the 
tubes and mixed well by inversion. 
6) The tubes ware capped with glass marbles to minimize 
evaporation and placed in a water bath at 800C for 15 minutes. 
7) The tubes were then cooled in tap water and the readings were 
observed in spectrophotometer at 540nm. 
CALCULATION:- 
 
 
 
 
2) PROTEIN BOUND HEXOSAMINE:- 
 Protein bound hexosamine was estimated by the method of 
Winzler.R.J 
 The Serum Proteins are precipitated by ethanol. The hexosamine 
is liberated from the glycoproteins by acid hydrolysis. It is acetylated 
with acetyl acetone and is treated with alkali to form a cyclic oxazole or 
pyrrole, and coupling with P-dimethylaminobenzaldehyde (Ehrlich’s 
Concentration of 
Protein bound 
hexose 
(mg%) 
 
= 
Test OD 
 
Standard  
OD 
 
X 
Concentration 
of standard 
Test volume 
 
x 
 
100 
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Reagent) to form a coloured derivation which is read photometrically at 
530nm. 
STANDARDIZATION:- 
 The standard used was glucosamine. The optical densities given 
by galactosamine are the same as those given by glucosamine, so that 
the use of glucosamine standard is justified. 
PREPARATION OF STANDARD SOLUTION:  
 Stock solution was prepared by dissolving 100mg of 
Glucosamine hydrochloride in 100ml of deionised water.   
 Working standard was prepared form 100mg% stock solution. 
Working standard 
concentration 
Stock solution  
(ml) 
Deionised water  
(ml) 
6mg% 0.6 9.4 
9mg% 0.9 9.1 
12mg% 1.2 8.8 
15mg% 1.5 8.5 
18mg% 1.8 8.2 
 
REAGENTS :- 
1) 95% Ethanol 
2) 3N Hcl 
3) 3N NaoH 
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4) Acetyl acetone Reagent – 1ml of acetyl acetone in 50ml of 0.5N 
Na2 co3 freshly prepared. 
3) Ehrlich’s Reagent – 0.8g of P-dimethylaminobenzaldehyde 
dissolved in 30ml of methanol and 30ml of conc. Hcl 
4) Glucosamine standard 0.06mg glucosamine Hcl/ml. 
PROCEDURE :- 
1) To 0.1ml of serum in a 15 x 150 mm test tube, 5ml of 95% 
ethanol is added and mixed. 
2) Centrifuged for 15 minutes, decanted and the precipitate was 
resuspended in 5ml of 95% ethanol, centrifuged and decanted. 
3) To the precipitated proteins, 2ml of 3N Hcl is added and is 
hydrolyzed in a boiling water bath with air condenser for 4hrs. 
4) The hydrolysate was neutralized with 3N until it is barely 
alkaline to litmus and diluted to 10 ml. 
5) To 1ml aliquots and to 1ml of water for a blank and 1ml of 
glucosamine standard 1ml of acetylacetone reagent is added and 
mixed. 
6) The tubes were capped with marbles to prevent evaporation and 
placed in the boiling water bath for 15min. 
7) The takes were cooled in tap water, and 5ml of 95% ethanol is 
added and mixed. 
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8) To this mixture, 1ml of Ehrlich’s reagent is added, mixed well 
and diluted to 10ml with 95% Ethanol. 
9) Readings was observed in spectrophotometer after 30 min at 
530nm.  
Calculation : 
Concentration of 
protein bound     =   
hexosamine 
(mg%) 
Test OD x  Test volume  
Standard OD Concentration of 
Standard. 
 
X 100 
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RESULT AND STATISTICAL ANALYSIS 
• Mean and standard deviation were estimated for each study group i.e 
cases and controls. 
• Data were expressed as mean + S.D 
• Data so obtained was analyzed to obtain appropriate conclusions. 
• Mean values were compared between cases and controls by using 
students independent‘t’ test. 
• Student‘t’ test was employed to find out the ‘p’ value. 
• Pearson’s correlation analysis was done to assures the relationship 
between the parameters, protein bound hexose and protein bound 
hexosamine in each study group. 
• The results of the present study are presented in Table 1. 
TABLE 1 
Mean standard deviation and test of significance of mean values 
between cases and controls. 
VARIABLE CASE CONTROL P.VALUE 
Mean + S.D 
(mg%) 
Mean + SD 
(mg%) 
Protein bound hexose 191.05 + 4.01 102.50 + 5.81 < 0.0001 
Protein bound 
hexosamine 97.50 + 5.06 78.50  + 4.97 < 0.0001 
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INFERENCE – TABLE 1 
• Mean protein bound hexose level in cases (191.05+4.01) was 
significantly higher than control (102.50 + 5.81). P < 0.0001. 
• Mean protein bound hexosamine in cases (97.50+5.06) was 
significantly higher than control (78.50 + 4.97). P < 0.0001. 
Correlation between P1 & P2 in each study group 
TABLE 2 
Group Correlation co 
efficient (r) 
P-Value 
Control  0.69 <0.0001 
Cases 0.42 0.047  
 
INFERENCE (TABLE 2) 
 For controls, there was a significant positive correlation between 
protein bound hexose and protein bound hexosamine (r=0.69, P<0.0001) 
 For cases, there was a positive correlation between PBH, PBHx 
and is statistically significant r=0.42 P=0.047. 
In the present study, P<0.05 was considered as the level of 
significance. 
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DISCUSSION 
In this study, a significant difference in mean concentrations of 
protein bound hexose and protein bound hexosamine was observed 
between normal healthy subjects and patients with severe depression. 
This study demonstrates that the level of serum glycoproteins 
protein bound hexose and protein bound hexosamine were elevated in 
Severe depressed patients relative to the control group. 
Narendra G. Mehta and Alamela Ventakaraman10 had reported 
that the concentration of the serum glycoprotein is elevated in patients 
suffering from wide variety of pathological conditions. 
Elevated serum glycoproteins represent a systemic response to 
non-specific stress and levels are affected by the pituitary adrenal axis. 
Depression is associated with high cortisol level and 
hyperactivity of hypothalamic  pituitary adrenal axis25,26. This probably 
explains the raised level of protein bound hexose and protein bound 
hexosamine in patients with depression.   
Depression also exhibits certain immune disturbance during acute 
episode as evidenced by high levels of serum alpha – 1- acid 
glycoprotein, increased C – reactive protein12 . Serum alpha – 1- acid 
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glycoprotein raise as a result of increased hepatic synthesis  stimulated 
by inflammatory cytokines27.  
Thus it is suggested from the present study that there is increase 
in serum levels of protein bound hexose and protein bound hexosamine 
in patients with severe depression.  This finding is due to glycosylation 
of proteins or be due to increased hepatic biosynthesis of glycoproteins 
or due to release of preformed proteins in patients of depression. 
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CONCLUSION 
The present study shows the diagnostic relevance of serum 
glycoproteins in depressive disorders.  Although serum glycoprotein 
levels appear to be one of the non-specific indicators of depression, it 
can be concluded on the basis of present study that serum glycoprotein 
levels serve as a useful marker in the diagnosis of patients with 
depressive disorders. 
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MASTER CHART 
 
CASES 
 
Sl.No. Name Age PB Hexose 
(Conc)mg%
PB  Hexosamine 
(Conc)mg% 
1)  Mallik Basha 53 194.47 100.00 
2)  Srinivasan 49 185.08 90.00 
3)  Ramesh 31 205.00 101.00 
4)  Mohandass 32 183.42 88.99 
5)  Jayanthi 27 187.84 88.00 
6)  Jessy 25 181.21 110.00 
7)  Panchavarnam 34 193.37 97.99 
8)  Jamuna 28 192.81 93.00 
9)  Mehabob 30 185.08 99.00 
10) Kavali 54 192.26 91.99 
11) Muthusamy 38 191.71 88.00 
12) Usha 42 187.29 88.99 
13) Stalin 29 192.26 110.00 
14) Thangammal 36 187.29 94.99 
15) Sridhar 43 187.84 99.00 
16) Veni 44 191.16 100.00 
17) Jamuna 35 186.74 101.00 
18) Mariappan 45 195.02 90.00 
19) Munisamy 33 191.16 101.00 
20) Karuppaiah 51 190.60 99.00 
21) Muthulakshmi  38 193.92 97.99 
22) Prema 36 188.95 94.99 
23) Arumugam 45 191.71 91.00 
24) Govindasamy 41 190.60 94.00 
25) Hari 27 191.16 99.00 
26) Krishnapriya 29 191.71 97.99 
27) Mani Megalai 31 194.47 100.00 
28) Dhanabakiyam 33 195.02 110.00 
29) Nazeer Ahmed 42 193.92 101.00 
30) John  46 194.47 99.00 
31) Mallika  52 191.16 97.99 
32) Ilayaraja 32 191.71 91.99 
33) Kumar 28 187.84 94.00 
34) Maheswari 31 192.26 100.00 
35) Jamuna 36 187.29 94.99 
36) Premkumar 39 195.02 100.00 
37) Arul 40 188.95 97.99 
38) Sabeena Banu 28 185.08 94.99 
39) Radhika 27 193.37 101.00 
40) Josephin 25 194.47 97.99 
41) Nafeeza 39 193.92 97.00 
42) Munirathinam 34 191.71 97.00 
43) Lalitha 29 195.02 101.00 
44) Ezhil 30 193.37 97.99 
45) Suresh 26 194.47 100.00 
46) Govindasamy 49 192.26 99.00 
47) Munirathinam 51 193.37 101.00 
48) Rasathi 42 185.08 97.99 
49) Padmavathi 32 191.16 99.00 
50) Meenakshi 36 187.84 91.99 
 
CONTROLS 
 
Sl.No. Name Age PB Hexose 
(Conc)mg%
PB  Hexosamine 
(Conc)mg% 
1. Mani 31 111.10 80.00 
2. Veni 27 106.07 70.00 
3. Ramkumar 29 105.00 82.00 
4. Gayathri 34 98.89 85.00 
5. Ganesh 40 105.00 80.00 
6. Madhavi 26 116.02 85.00 
7. Karunanidhi 52 111.10 84.00 
8. Saroja 41 99.44 79.00 
9. Annie 28 100.55 80.00 
10. Savithri 33 105.00 82.00 
11. Chellammal 38 94.60 79.00 
12. Meenakshi 37 100.55 81.00 
13. Subitha 30 111.10 83.00 
14. Kousalya 44 105.52 80.00 
15. Rajan 48 94.60 75.00 
16. Mohan 39 105.50 82.00 
17. Kanimozhi 29 88.39 60.00 
18. Arumugam 41 94.60 70.00 
19. Jayanthi 35 100.55 80.00 
20. Sengamalam 35 106.07 82.00 
21. Chandran 32 109.18 84.00 
22. Kannan 49 102.20 79.00 
23. Srinivasan 46 106.01 82.00 
24. Jamuna 39 94.06 70.00 
25. Anitha 36. 105.52 80.00 
26. Dinesh 29 88.80 70.00 
27. Kamalam 40 105.50 81.00 
28. Radha 37 106.07 82.00 
29. Chelladurai 38 100.55 71.00 
30. Ramakrishnan 46 98.34 71.00 
31. Jeyaraman 27 100.00 70.00 
32. Latha 29 98.89 71.00 
33. Devi 35 106.07 80.00 
34. Maheswari 52 108.28 81.00 
35. Lakshmi Priya 32 97.79 79.00 
36. Sivashanmugam 29 107.18 81.00 
37. Ramesh 32 102.20 80.00 
38. Krishnan 45 100.55 79.00 
39. Karthika 26 105.52 81.00 
40. Selvavinayagam 45 92.26 78.00 
41. Vijayalakshmi 42 108.28 82.00 
42. Sakthi 30 106.62 81.00 
43. Venu 28 106.07 81.00 
44. Thangam 32 102.20 79.00 
45. Thambidurai 29 94.60 78.00 
46. Mayilu 39 105.00 81.00 
47. Kandhasamy 40 106.07 80.00 
48. Thangavelu 38 98.89 78.00 
49. Lakshmi Narayanan 25 102.20 79.00 
50. Perumal 35 99.44 77.00 
 
 
PROFORMA 
 
 
Date : 
Stanley Medical College Hospital 
 
Name   :      OP No..  
Age    : 
Sex   :  
Occupation  : 
Clinical History : 
 
 
 
On Examination  : 
 
Investigation  : 
1) Protein Bound Hexose :  mg/dL 
2) Protein Bound Hexosamine :  mg/dL 
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REVIEW OF LITERATURE 
1) Fatemi SH, Kroll JL, Stary JK had studied the altered levels of Reelin and 
its isoforms in mood disorders (Bipolar disorder and major depression) and 
schizophrenia. They reported that blood Reelin levels and its  isoforms may 
be used as potential peripheral markers to diagnose presence of several 
psychiatric disorders and may also serve as targets for further therapeutic 
interventions. 
2) Sluzewska A, Rybakowski JK et al reported high level of Alpha -1-acid 
glycoproteins and its microheterogencity in patients with major depressive 
disorder. 
3) Bondy B. Baghai TC, Minov C et al reported increased levels of substance 
‘P’  in major depression. 
4) Healy D, Calvin J, White house AM et al studied about the level of Alpha -
1- acid glycoprotein in major depressive and eating disorders. 
5) Kehoe WA, Kwentus JA, Sheffol WB, Harralson AF, reported increased 
alpha 1 – acid glycoprotein in depression lowers free fraction of 
imipramine. 
6) Bruce EC, Mussel man D L studied about depression, alterations in platelet 
function and Ischemic heart disease. They observed that depression is also 
associated with complex platlet abnormalities such as increased 
concentrations of functional glycoproteins 11b/111a receptors. 
PSYCHOLOGICAL SIGNIFICANCE OF SERUM GLYCOPROTEINS2 
 
Sibert F.B. et al suggested the elevations of Glycoprotein above normal 
level reflect process of tissue destruction.  In support of the view that tissue 
destruction contributes directly to the serum glycoprotein levels is the observation 
that more glycoprotein carbohydrate is found in venous blood than in arterial 
blood. 
Direct release of preformed glycoprotein from inflamed tissue is a 
possibility.  Equally possible is the increased local synthesis and liberation of the 
glycoprotein by inflammation tissue. 
The increased serum glycoprotein levels in disease reflect in whole or in 
part, processes associated with tissue proliferation26,27. Elevations in serum 
glycoproteins are frequently associated with conditions in which destruction is not 
pronounced and cell proliferation or protein syntheis is rapid. Eg. prostatic 
hyperplasia, pregnancy. 
Elevated serum glycoproteins may represent a systemic response to non-
specific stress. The wide variety of conditions which result in high serum 
glycoprotein levels would tend to support this contention and would suggest that 
the levels of serum glycoproteins might be affected by the pituitary adrenal axis. 
 
DISCUSSION 
In this study, a significant difference in mean concentrations of protein bound 
hexose and protein bound hexosamine was observed between normal healthy 
subjects and patients with severe depression. 
This study demonstrates that the level of serum glycoproteins protein bound 
hexose and protein bound hexosamine were elevated in depressed patients relative 
to the control group. 
Narendra G. Mehta and Alamela Ventakaraman10 had reported that the 
concentration of the serum glycoprotein is elevated in patiens suffering from wide 
variety of pathological conditions. 
Elevated serum glycoproteins represent a systemic response to non-specific stress 
and levels are affected by the pituitary adrenal axis. 
Depression is associated with high cortisol level and hyperacivity of hypothalamic c 
pituitary adrenal axis. This probably explains the raised level of protein bound 
hexose and protein bound hexosamine in patints with depression.   
Depression also exhibits certain immune disturbance during acute episode as 
evidenced by high levels of serum alpha – 1- acid glycoprotein, increased C – 
reactive protein and serum alpha – 1- acid glycoprotein raise as a result of 
increased hepatic syntheis  stimulated by inflammatory cytokines.  
Thus it is suggested from the present study that there is increase in serum levels of 
protein bound hexose and protein bound hexosamine in patients with severe 
depression.  This finding is due to glycosylation of proteins or be due to increased 
hepatic biosynthesis of glycoproteins or due to release of proformed proteins in 
patients of depression. 
CONCLUSION 
The present study shows the diagnostic relevance of serum glycoproteins in 
depressive disorders.  Although serum glycoprotein levels appear to be one of the 
non-specific indicators of depression, it can be concluded on the basis of present 
study that serum glycoprotein levels serve as a useful marker in the diagnosis of 
patients with depressive disorders. 
 
  
